Hohimer Wealth Management LLC purchased a new position in Waters Corporation (NYSE:WAT – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,341 shares of the medical instruments supplier’s stock, valued at approximately $589,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ashton Thomas Securities LLC boosted its position in shares of Waters by 3.5% during the 3rd quarter. Ashton Thomas Securities LLC now owns 704 shares of the medical instruments supplier’s stock worth $309,000 after purchasing an additional 24 shares in the last quarter. Caitlin John LLC grew its stake in shares of Waters by 43.9% in the 2nd quarter. Caitlin John LLC now owns 82 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 25 shares during the period. Park Avenue Securities LLC grew its stake in shares of Waters by 2.8% in the 3rd quarter. Park Avenue Securities LLC now owns 910 shares of the medical instruments supplier’s stock valued at $400,000 after buying an additional 25 shares during the period. Kingswood Wealth Advisors LLC increased its position in Waters by 3.7% in the 3rd quarter. Kingswood Wealth Advisors LLC now owns 786 shares of the medical instruments supplier’s stock valued at $345,000 after buying an additional 28 shares in the last quarter. Finally, Avalon Trust Co increased its position in Waters by 2.3% in the 1st quarter. Avalon Trust Co now owns 1,330 shares of the medical instruments supplier’s stock valued at $396,000 after buying an additional 30 shares in the last quarter. 94.01% of the stock is owned by institutional investors.
Waters Trading Up 4.3%
NYSE:WAT opened at $477.12 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.66 and a quick ratio of 1.29. The firm has a 50-day moving average of $435.97 and a 200-day moving average of $372.64. The company has a market cap of $46.88 billion, a PE ratio of 204.77, a PEG ratio of 2.71 and a beta of 1.16. Waters Corporation has a one year low of $282.77 and a one year high of $482.28.
Waters (NYSE:WAT – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.00 by $0.10. Waters had a net margin of 1.75% and a return on equity of 9.91%. The business had revenue of $1.77 billion for the quarter, compared to analysts’ expectations of $1.75 billion. During the same quarter last year, the firm earned $3.40 EPS. The firm’s revenue for the quarter was up 120.9% compared to the same quarter last year. As a group, equities research analysts expect that Waters Corporation will post 14.65 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on WAT. Wells Fargo & Company upped their price target on Waters from $370.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 5th. Sanford C. Bernstein reissued an “outperform” rating and issued a $535.00 price objective on shares of Waters in a research note on Wednesday, November 4th. Wall Street Zen upgraded Waters from a “hold” rating to a “buy” rating in a report on Monday, October 26th. Leerink Partners upped their target price on Waters from $420.00 to $450.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Finally, Stifel Nicolaus set a $470.00 target price on Waters in a research report on Wednesday, November 4th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $475.48.
View Our Latest Research Report on WAT
Waters Profile
Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.
The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.
Founded in 1958 by James L.
Featured Stories
- Five stocks we like better than Waters
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
